does insurance cover glp 1 for diabetes Costly GLP-1 Drugs are Rarely Covered Weight Loss by Marketplace Plans Insurer strategies to control costs

They can provide you with detailed information about your policy, including any requirements, co-pays, and restrictions related to semaglutide GLP-1 coverage

The headline results, as released in the Eli Lilly investor communication and aligned with the study design paper by Giblin and colleagues published in Diabetes, Obesity and Metabolism in 2026, are unusually strong for a Phase 3 obesity trial: Retatrutide 12 mg: mean body-weight reduction of 28.7 percent, roughly 32.3 kg (about 71.2 lbs) from baseline

However, the pivotal 36-week Phase 2 trial showed a larger range of mean loss, from 9.4% to 14.7%, across doses, confirming robust dose-dependent effects

Figure 4 illustrates the potential pathways of the function of GLP-1RAs against multiple diseases

Int J Epidemiol 49(3):740741e